Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

LOSARTAN POTASSIUM

FDA · NDA · 2026-02-18

AgencyFDA
Submission typeNDA
Action date2026-02-18
BrandARBLI
SponsorSCIENTURE
RouteORAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:22.864Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:LOSARTAN POTASSIUM:2026-02-18

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

LOSARTAN POTASSIUM — approval | AEaH